The benefits of SMBG for patients with type 1 diabetes mellitus and for insulin-treated patients with type 2 diabetes mellitus are well established, whereas those for non–insulin-treated patients have been questioned [7]. The gene discussed is INS; the disease is type 2 diabetes mellitus.